Chronic stress primes innate immune responses in mice and humans

Cell Rep. 2021 Sep 7;36(10):109595. doi: 10.1016/j.celrep.2021.109595.

Abstract

Psychological stress (PS) is associated with systemic inflammation and accelerates inflammatory disease progression (e.g., atherosclerosis). The mechanisms underlying stress-mediated inflammation and future health risk are poorly understood. Monocytes are key in sustaining systemic inflammation, and recent studies demonstrate that they maintain the memory of inflammatory insults, leading to a heightened inflammatory response upon rechallenge. We show that PS induces remodeling of the chromatin landscape and transcriptomic reprogramming of monocytes, skewing them to a primed hyperinflammatory phenotype. Monocytes from stressed mice and humans exhibit a characteristic inflammatory transcriptomic signature and are hyperresponsive upon stimulation with Toll-like receptor ligands. RNA and ATAC sequencing reveal that monocytes from stressed mice and humans exhibit activation of metabolic pathways (mTOR and PI3K) and reduced chromatin accessibility at mitochondrial respiration-associated loci. Collectively, our findings suggest that PS primes the reprogramming of myeloid cells to a hyperresponsive inflammatory state, which may explain how PS confers inflammatory disease risk.

Trial registration: ClinicalTrials.gov NCT03022552.

Keywords: inflammation; metabolism; monocytes; priming; psychological stress; women.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / metabolism*
  • Humans
  • Immunity, Innate / drug effects
  • Immunity, Innate / immunology*
  • Immunologic Memory / drug effects
  • Immunologic Memory / immunology*
  • Inflammation / immunology*
  • Inflammation / metabolism
  • Inflammation Mediators / metabolism
  • Macrophages / metabolism
  • Mice
  • Mitochondria / immunology
  • Mitochondria / metabolism
  • Monocytes / metabolism
  • Stress, Physiological / immunology*

Substances

  • Cytokines
  • Inflammation Mediators

Associated data

  • ClinicalTrials.gov/NCT03022552